Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Programmed death receptor ligand-2 (PD-L2) bearing extracellular vesicles as a new biomarker to identify early triple-negative breast cancer patients at high risk for relapse
Oliver Hoffmann, Sebastian Wormland, Ann‐Kathrin Bittner, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 3, pp. 1159-1174
Open Access | Times Cited: 13

Showing 13 citing articles:

Filter-aided extracellular vesicle enrichment (FAEVEr) for proteomics
Jarne Pauwels, Tessa Van de Steene, J. Van De Velde, et al.
Molecular & Cellular Proteomics (2025), pp. 100907-100907
Open Access
Therapeutic Implications of the Drug Resistance Conferred by Extracellular Vesicles Derived from Triple-Negative Breast Cancer Cells
Yong Weon Yi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3704-3704
Open Access | Times Cited: 12
The role of extracellular vesicle immune checkpoints in cancer
Weiming Zhang, Mingrong Ou, Ping Yang, et al.
Clinical & Experimental Immunology (2024) Vol. 216, Iss. 3, pp. 230-239
Open Access | Times Cited: 3
MicroRNAs with Multiple Targets of Immune Checkpoints, as a Potential Sensitizer for Immune Checkpoint Inhibitors in Breast Cancer Treatment
Huiling Zhou, Wentao Jia, Lingeng Lu, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 824-824
Open Access | Times Cited: 9
Immune Checkpoint Profiling in Humanized Breast Cancer Mice Revealed Cell-Specific LAG-3/PD-1/TIM-3 Co-Expression and Elevated PD-1/TIM-3 Secretion
Christina Bruß, Kerstin Kellner, Veruschka Albert, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2615-2615
Open Access | Times Cited: 8
Extracellular Vesicles in Breast Cancer: From Intercellular Communication to Therapeutic Opportunities
Muttiah Barathan, Sook Luan Ng, Yogeswaran Lokanathan, et al.
Pharmaceutics (2024) Vol. 16, Iss. 5, pp. 654-654
Open Access | Times Cited: 2
Do different exosome biogenesis pathways and selective cargo enrichment contribute to exosomal heterogeneity?
Shatakshi Shukla, Fatema Currim, Rajesh Singh
Biology of the Cell (2023) Vol. 115, Iss. 7
Closed Access | Times Cited: 5
PD‐L2 Expression in Breast Cancer Promotes Tumor Development and Progression
Yuling Sun, Jie Yang, Yachun Chen, et al.
Journal of Immunology Research (2024) Vol. 2024, Iss. 1
Open Access
Advancements and Clinical Significance of Breast Cancer Exosome Detection
Xinjie Zhou
Transactions on Materials Biotechnology and Life Sciences (2024) Vol. 3, pp. 91-103
Open Access
Identification of DLAT as a potential therapeutic target via a novel cuproptosis-related gene signature for the prediction of liver cancer prognosis
Cunbing Xia, Yang Chen, Yongkang Zhu, et al.
Journal of Gastrointestinal Oncology (2024) Vol. 15, Iss. 5, pp. 2230-2251
Open Access
Filter-aided extracellular vesicle enrichment (FAEVEr) for proteomics
Jarne Pauwels, Tessa Van de Steene, J. Van De Velde, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
PD-1 Blockage Facilitates Cytotoxic T and NK Cells Tumoricidal Phenotype in a Murine Breast Carcinoma
Sanja Tripković, Miodrag Jocić, Isidora Stanisavljević, et al.
Experimental and Applied Biomedical Research (EABR) (2023)
Open Access
Exosomal prognostic biomarkers predict metastatic progression and survival in breast cancer patients
Ceyhan Ceran Serdar, Şeyma Osmanlıoğlu
Turkish Journal of Biochemistry (2023) Vol. 48, Iss. 5, pp. 541-562
Open Access
Page 1

Scroll to top